ZA975986B - N-alkoxyadenine derivatives acting as cytokine inhibitors. - Google Patents

N-alkoxyadenine derivatives acting as cytokine inhibitors.

Info

Publication number
ZA975986B
ZA975986B ZA9705986A ZA975986A ZA975986B ZA 975986 B ZA975986 B ZA 975986B ZA 9705986 A ZA9705986 A ZA 9705986A ZA 975986 A ZA975986 A ZA 975986A ZA 975986 B ZA975986 B ZA 975986B
Authority
ZA
South Africa
Prior art keywords
alkoxyadenine
cytokine inhibitors
derivatives acting
derivatives
acting
Prior art date
Application number
ZA9705986A
Inventor
Lars Knutsen
Uffe Bang Olsen
Stanley M Roberts
David R Varley
Andrew Neil Bowler
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA975986B publication Critical patent/ZA975986B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9705986A 1996-07-05 1997-07-04 N-alkoxyadenine derivatives acting as cytokine inhibitors. ZA975986B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK74596 1996-07-05

Publications (1)

Publication Number Publication Date
ZA975986B true ZA975986B (en) 1998-03-23

Family

ID=8097056

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9705986A ZA975986B (en) 1996-07-05 1997-07-04 N-alkoxyadenine derivatives acting as cytokine inhibitors.

Country Status (3)

Country Link
AU (1) AU3255097A (en)
WO (1) WO1998001459A1 (en)
ZA (1) ZA975986B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU44900A (en) * 1998-01-31 2003-01-31 Glaxo Group Limited 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
GB9813554D0 (en) * 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds
US6495528B1 (en) * 1998-06-23 2002-12-17 Smithkline Beecham Corporation 2-(Purin -9-yl)-tetrahydrofuran-3,4-diol derivatives
GB9813535D0 (en) * 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds
GB9813540D0 (en) * 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds
AU2002323990B2 (en) * 1998-06-23 2006-03-30 Glaxo Group Limited Adenosine derivatives
GB9813565D0 (en) * 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds
WO2001002400A1 (en) 1999-07-02 2001-01-11 Eisai Co., Ltd. Fused imidazole compounds and remedies for diabetes mellitus
GB0022695D0 (en) 2000-09-15 2000-11-01 Pfizer Ltd Purine Derivatives
GB0106867D0 (en) 2001-03-20 2001-05-09 Glaxo Group Ltd Process
AU2002951247A0 (en) 2002-09-06 2002-09-19 Alchemia Limited Compounds that interact with kinases
JP2006516641A (en) * 2003-02-03 2006-07-06 シーブイ・セラピューティクス・インコーポレイテッド Full and partial agonists of adenosine receptors
PE20060272A1 (en) 2004-05-24 2006-05-22 Glaxo Group Ltd (2R, 3R, 4S, 5R, 2'R, 3'R, 4'S, 5'S) -2.2 '- {TRANS-1,4-CYCLOHEXANODIYLBIS- [IMINO (2 - {[2- (1-METHYL- 1H-IMIDAZOL-4-IL) ETHYL] AMINO} -9H-PURIN-6,9-DIYL)]} BIS [5- (2-ETHYL-2H-TETRAZOLE-5-IL) TETRAHYDRO-3,4-FURANODIOL] AS AN A2A AGONIST
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
WO2013120078A1 (en) 2012-02-11 2013-08-15 Academia Sinica Methods and compositions for treating pain
CN108676048B (en) * 2018-06-04 2021-04-27 上海兆维科技发展有限公司 Preparation method of cordycepin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962194A (en) * 1987-04-02 1990-10-09 Warner-Lambert Company Method of preparing 51,N6-disubstituted adenosines from inosines
IL108523A0 (en) * 1993-02-03 1994-05-30 Gensia Inc Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain

Also Published As

Publication number Publication date
WO1998001459A1 (en) 1998-01-15
AU3255097A (en) 1998-02-02

Similar Documents

Publication Publication Date Title
HUP0001848A3 (en) 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
AU4073997A (en) 1,4-heterocyclic metallprotease inhibitors
PL331338A1 (en) Thiosulphonamidic metaloprotease inhibitors
ZA978452B (en) Hetaroyl derivatives
ZA97521B (en) 19-Nor-pregnene derivatives.
ZA978451B (en) Hetaroyl derivatives
ZA9811599B (en) Ortho-anthranilamide derivatives as anti-coagulants.
AP9700954A0 (en) 6-ohenylpyridyl-2-amine derivatives
ZA978045B (en) New benzamidine derivatives.
ZA975986B (en) N-alkoxyadenine derivatives acting as cytokine inhibitors.
HK1018457A1 (en) Alkylaminobenzothiazole and-benzoxazole derivatives.
PL331803A1 (en) Bidonoric metaloprotease inhibitors
AU3944497A (en) 1,2-diarylindole as cox-2 inhibitors
IL126624A0 (en) 3-descladinose-2, 3-anhydroerythromycin derivatives
AU5652698A (en) (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors
HUP9701835A3 (en) Vinyl-pirrolidinone-cephalosporin derivatives
ZA974953B (en) Substituted pyrazolylpyrazole derivatives.
ZA979725B (en) Benzoaxozole derivative.
ZA978086B (en) New pyranoside derivatives.
IL125149A0 (en) Pyrazol-4-yl-hetaroyl derivatives
HU9701479D0 (en) N-benzylazolium derivatives
GB9604996D0 (en) Benzodiazonine derivatives
ZA971167B (en) Heterocyclyl-ergoline derivatives.
CY2322B1 (en) Benzoaeguequinoline derivatives.
GB2333294B (en) Cytokine production inhibitors